Infliximab
Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring
Optimizing Management with Anti-TNF Levels and Antibodies
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect
Adalimumab/Infliximab Therapeutic Drug Monitoring | IBD Clinic
Algorithm for use of reactive therapeutic drug monitoring in IBD... | Download Scientific Diagram
Medical Tests to Get Before Starting Biologics
1 Scottish Biologic Therapeutic Drug Monitoring Service –Gastroenterology Guidance The purpose of this document is to provide
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
Monitoring your medication | Crohn's & colitis
Adalimumab Level with Reflex to Adalimumab Antibody
Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis | Scientific Reports
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
The 'Nuts and Bolts' of Drug Concentration Monitoring in IBD | GI and Hepatology News
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
Adalimumab | Crohn's & Colitis UK
Available now: The complete package for Therapeutic Drug Monitoring
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Therapeutic Drug Monitoring - Gastrointestinal Society
Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis | Reumatología Clínica
ADALIMUMAB
Adalimumab | Crohn's & Colitis UK
